- 收听数
- 0
- 性别
- 保密
- 听众数
- 20
- 最后登录
- 2022-12-28
- QQ
 - UID
- 14168
- 阅读权限
- 20
- 帖子
- 261
- 精华
- 0
- 在线时间
- 53 小时
- 注册时间
- 2015-6-17

- 科研币
- 5
- 速递币
- 298
- 娱乐币
- 1721
- 文献值
- 3
- 资源值
- 0
- 贡献值
- 0
|
5速递币
题名 | A randomized multicenter phase III study of cetuximab (Erbitux®) in combination with Taxane/Carboplatin versus Taxane/Carboplatin alone as first-line treatment for patients with advanced/metastatic Non-small cell lung cancer (NSCLC): B3-03 | 作者 | Lynch, Thomas J.1; Patel, Taral2; Dreisbach, Luke3; McCleod, Michael4; Heim, William J.5; Robert, | 杂志 | Journal of Thoracic Oncology | 年|卷|期 | August 2007 - Volume 2 - Issue 8 | 页码 | pp S340-S341 | 链接 | http://journals.lww.com.sci-hub.club/jto/Citation/2007/08001/A_randomized_multicenter_phase_III_study_of.241.aspx |
急求一篇会议文献,谢谢 |
最佳答案
cuiwq456 查看完整内容
http://journals.lww.com/jto/Fulltext/2007/08001/A_randomized_multicenter_phase_III_study_of.241.aspx
免费论文,从目录看该文无pdf版。
|